Tectonic Therapeutic, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TECX Nasdaq 2836 tectonictx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tectonic Therapeutic, Inc.

Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients - Jun 10th, 2026 2:01 pm
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights - May 7th, 2026 2:01 pm
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - May 1st, 2026 8:24 am
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors - Apr 23rd, 2026 2:01 pm
TD Asset Management Inc. Announces TD ETF Distributions - Mar 19th, 2026 8:00 am
Tectonic Therapeutic to Participate in March Investor Conferences - Mar 2nd, 2026 6:00 am
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Feb 26th, 2026 2:17 pm
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins - Feb 25th, 2026 2:18 am
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - Feb 23rd, 2026 2:01 pm
Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic - Feb 14th, 2026 5:00 am
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026 - Feb 11th, 2026 2:01 pm
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating - Dec 10th, 2025 12:13 pm
Tectonic Therapeutic to Participate in December Investor Conferences - Dec 1st, 2025 6:00 am
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights - Nov 6th, 2025 2:01 pm
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF - Oct 29th, 2025 2:01 pm
Bullish Tectonic Therapeutic Insiders Loaded Up On US$61.2m Of Stock - Oct 12th, 2025 7:26 am
Tectonic Therapeutic to Participate in September Investor Conferences - Aug 28th, 2025 7:00 am
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights - Aug 7th, 2025 2:01 pm
Tectonic Therapeutic Joins Russell 3000® Index - Jun 30th, 2025 6:00 am
Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating - Jun 24th, 2025 3:42 pm